drugset / Trial / NCT05062876
A Study to Compare PK, PD and Safety of the AD-214 and AD-2141
RandomizedCrossoverOpen-labelTreatment
Summary
A study to compare safety, pharmacokinetics and pharmacodynamics of AD-214 to AD-2141 in healthy volunteers.
Timeline
- Start
- 2021-11-01
- Primary completion
- 2022-03-17
- Completion
- 2022-03-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AD-214 | Protein / enzyme biologic | — | — |
| Comparator | AD-2141 | Unknown | — | — |